OVIT (OncoVista Innovative Therapies) Cyclically Adjusted Book per Share: $0.00 (As of Sep. 2015)


What is OncoVista Innovative Therapies Cyclically Adjusted Book per Share?

OncoVista Innovative Therapies OVIT Cyclically Adjusted Book per Share is $0.00 as of Sep. 2015.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

OncoVista Innovative Therapies's adjusted book value per share for the three months ended in Sep. 2015 was $-0.280. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Sep. 2015.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-06-27), OncoVista Innovative Therapies's current stock price is $0.0001. OncoVista Innovative Therapies's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2015 was $0.00. OncoVista Innovative Therapies's Cyclically Adjusted PB Ratio of today is .


OncoVista Innovative Therapies  (OTCPK:OVIT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


OncoVista Innovative Therapies Cyclically Adjusted Book per Share Related Terms


OncoVista Innovative Therapies Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Cyclically Adjusted Book per Share Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OVIT vs RSPI, HSTC, CAPS: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OncoVista Innovative Therapies Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's Cyclically Adjusted PB Ratio falls into.



OncoVista Innovative Therapies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OncoVista Innovative Therapies's adjusted Book Value per Share data for the three months ended in Sep. 2015 was:

Adj_Book= Book Value per Share /CPI of Sep. 2015 (Change)*Current CPI (Sep. 2015)
=-0.28/237.9450*237.9450
=-0.280

Current CPI (Sep. 2015) = 237.9450.

OncoVista Innovative Therapies Quarterly Data

Book Value per Share CPI Adj_Book
200512 -0.093 196.800 -0.112
200603 -0.101 199.800 -0.120
200606 -0.102 202.900 -0.120
200609 -0.103 202.900 -0.121
200612 -0.330 201.800 -0.389
200703 -0.110 205.352 -0.127
200706 -0.113 208.352 -0.129
200709 0.000 208.490 0.000
200712 -0.229 210.036 -0.259
200803 -0.341 213.528 -0.380
200806 -0.343 218.815 -0.373
200809 -0.371 218.783 -0.403
200812 -0.411 210.228 -0.465
200903 -0.429 212.709 -0.480
200906 -0.493 215.693 -0.544
200909 -0.534 215.969 -0.588
200912 -0.530 215.949 -0.584
201003 -0.501 217.631 -0.548
201006 -0.482 217.965 -0.526
201009 -0.540 218.439 -0.588
201012 0.078 219.179 0.085
201103 0.046 223.467 0.049
201106 0.025 225.722 0.026
201109 0.013 226.889 0.014
201112 -0.006 225.672 -0.006
201203 -0.036 229.392 -0.037
201206 -0.046 229.478 -0.048
201209 -0.062 231.407 -0.064
201212 -0.078 229.601 -0.081
201303 -0.098 232.773 -0.100
201306 -0.110 233.504 -0.112
201309 -0.127 234.149 -0.129
201312 -0.144 233.049 -0.147
201403 -0.158 236.293 -0.159
201406 -0.200 238.343 -0.200
201409 -0.189 238.031 -0.189
201412 -0.257 234.812 -0.260
201503 -0.270 236.119 -0.272
201506 -0.320 238.638 -0.319
201509 -0.280 237.945 -0.280

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.00 mean?
OncoVista Innovative Therapies (OVIT) has a Cyclically Adjusted Book per Share of $0.00 as of Sep. 2015. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Cyclically Adjusted Book per Share too high?
OncoVista Innovative Therapies' current Cyclically Adjusted Book per Share is $0.00.
How does OncoVista Innovative Therapies' Cyclically Adjusted Book per Share compare to RSPI and HSTC?
OncoVista Innovative Therapies' Cyclically Adjusted Book per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Cyclically Adjusted Book per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Cyclically Adjusted Book per Share of $0.00. The current Cyclically Adjusted Book per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Cyclically Adjusted Book per Share is $0.00 as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.